Home > Healthcare & Medical Devices > Blood Testing Market

Blood Testing Market Size By Test Type (Complete Blood Count Test, Kidney Test- Renal Profile, Cholesterol Test- Lipid Profile Test, Blood Glucose Test, Antibodies Test – Rheumatoid Factor, Urine Test, Infectious Disease Screening, Cancer Test, Heart Test), By Product (Instruments, Reagents & Kits, Software), By Method (Manual, Automated), By End-use (Hospitals, Pathology Labs, Blood Banks, Diagnostic Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030

  • Report ID: GMI2683
  • Published Date: Sep 2022
  • Report Format: PDF

Industry Overview

Blood Testing Market size was valued at USD 70.5 billion in 2021 and is expected to depict a CAGR of over 6.5% through 2030. Surging prevalence of acute disorders such as chronic kidney disease (CKD), cardiovascular diseases, cancer, and diabetes will boost the market expansion.

Get more details on this report - Request Free Sample PDF

According to the Centers for Diseases Control and Prevention (CDC), around 15% of adults in the United States are estimated to be diagnosed with CKD (chronic kidney disease). Furthermore, according to estimates from the World Health Organization (WHO), cancer is becoming a leading cause of death across the world. This rising prevalence of chronic disorders and the subsequent increase in demand for prevention and control techniques will bolster market dynamics.

The growing prevalence of diabetes will increase the deployment of blood glucose tests

In terms of test type, the blood testing market is bifurcated into complete blood count test, blood glucose test, heart test, infectious disease screening, kidney test-renal profile, cholesterol test-lipid profile test, cancer test, urine test, antibodies-rheumatoid factor, and others.

Get more details on this report - Request Free Sample PDF

The blood glucose test segment is projected to exhibit a CAGR of over 6% through 2030. This is credited to the growing prevalence of diabetes across the globe. As per the WHO data, the prevalence of diabetes in 2021 grew significantly faster in middle- and low-income nations as compared to high-income countries. Moreover, according to statistics from the International Diabetes Federation (IDF), around 537 million adults aged between 20 to 79 years were diagnosed with diabetes in 2021. This growing disease burden has created significant demand for monitoring options such as blood glucose tests, in turn augmenting segment progre

Emergence of novel products with regulatory approval to stimulate demand for blood testing instruments

Get more details on this report - Request Free Sample PDF

By product, the blood testing market is divided into reagents & kits, instruments, and software. The instruments segment is projected to depict a CAGR of over 6.5% during the forecast period. The COVID-19 outbreak provided substantial opportunities for introducing and expanding advanced blood testing products authorized by regulatory bodies. The introduction of novel products such as these, along with strong regulatory support will spur the market forecasts.

Heavy investments in healthcare to augment demand for manual blood testing method

Get more details on this report - Request Free Sample PDF

Based on method, the blood testing market is segregated into automated and manual. The manual segment is anticipated to exhibit over 5% CAGR through 2030. This is owing to the growing investment interest in the healthcare sector. To extend product reachability, some industry players are becoming involved in the development and introduction of advanced products. Developments such as these are likely to expedite market value from the manual segment.

Rising availability of blood testing devices in diagnostic centers to bolster market outlook

Get more details on this report - Request Free Sample PDF

As per end-use, the market is classified into hospitals, diagnostic centers, pathology labs, blood banks, and others. The diagnostics centers segment is projected to hold a business share of over 20% by 2030. The growing availability of multiple user-friendly, portable, and precise blood testing devices is a key factor propelling this growth. Moreover, the rising adoption rate of biosensors owing to their ease of usage will fuel segment demand.

Expanding elderly population in Europe to augment product demand

Get more details on this report - Request Free Sample PDF

Europe blood testing market is set to cross USD 30 billion by 2030. The growing elderly population in addition to the rising prevalence of diabetes and complications associated with the disease will propel market trends. According to Eurostat, in 2021, around 20.8% of the population in the European Union was aged 65 years and over. This rise in the geriatric population susceptible to chronic illnesses is expected to influence regional market statistics.

Key partnerships among prominent players to expand the business landscape

Some of the major companies operating in the blood testing market comprise Abbott Laboratories, F Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, Danaher (Beckman Coulter Inc. and Radiometer), BioMerieux SA., Biomerica, Grifols, A.S, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Siemens Healthineers, Sinocare Inc. (NIPRO Diagnostics), Trinity Biotech, B. Braun Melsungen AG.

Prominent players are involved in strategic partnerships to reinforce their market position. Citing an instance, in May 2022, Danaher partnered with Smart4Diagnostics to bridge the gap between collection and laboratory analysis of blood. Delay in blood testing or analysis generally results in erroneous outcomes. This collaboration was intended to help the company mitigate pre-analytical errors in real-time and enhance the overall quality of the treatment.

Impact of COVID-19 on blood testing market share

The COVID-19 outbreak emerged as a critical health crisis, creating problems related not just to the respiratory system, but also causing blood-related problems. According to Johns Hopkins Medicine, some patients infected with the SARS-CoV-2 virus developed abnormal blood clotting in the legs and lungs. This issue prompted healthcare organizations to perform blood tests on patients infected with the virus, creating a favorable environment for blood testing industry development.

Furthermore, non-COVID-19 patients with problems such as cardiovascular disorders and cancer continued with regular check-ups, including blood tests. The growing prevalence of these conditions during the pandemic will thus positively impact market revenue.

The blood testing market research report includes in-depth coverage of the industry with estimates & forecasts in terms of “USD” from 2018 to 2030 for the following segments:

By Test type

  • Complete blood count test
  • Blood glucose test
  • Heart test
  • Infectious disease screening
  • Kidney Test- renal profile
  • Cholesterol test- lipid profile test
  • Cancer test
  • Urine test
  • Antibodies test – rheumatoid factor
  • Others

By Product

  • Reagents & kits
  • Instruments
  • Software

By Method

  • Automated
  • Manual

By End-use

  • Hospitals
  • Pathology labs
  • Blood banks
  • Diagnostic centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Others


Authors: Rupali Swain, Subodh Kharad

Frequently Asked Questions (FAQ) :

The global market for blood testing was valued at over USD 70.5 billion in 2021 and is projected to exhibit a CAGR of over 6% through 2030, due to the growing incidence of chronic disorders.
The blood glucose testing segment is expected to grow at a CAGR of more than 6% through 2030 with the surging prevalence of diabetes.
Europe blood testing market is projected to be valued at over USD 30 billion by 2030, due to a rise in the geriatric population in the region.
F Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, Danaher (Beckman Coulter Inc. and Radiometer), BioMerieux SA are some of the major players in the market.

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 13
  • Tables & Figures: 238
  • Countries covered: 15
  • Pages: 275
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount